In a good-news-bad-news week for Biogen, the company will cut an undisclosed number of employees, just as a higher dose of ...

Health activists and patients with spinal muscular atrophy (SMA) have refuted the Central government’s affidavit in the Kerala High Court and demanded urgent action to reduce the cost of ...

Biogen BIIB announced that the FDA and EMA have accepted its regulatory filings seeking label expansion for a higher dose of ...

More research is needed to confirm gray matter, the darker tissue found in the brain and spinal cord, “as a potential disease ...

for patients of spinal muscular atrophy (SMA) costs Rs 72 lakhs a year in India. A case in this regard has been going on in the Kerala High Court for a while now. On 22nd the Central government ...

The following is a summary of “Spinal cord gray matter atrophy is associated with disability in spinal muscular atrophy,” ...

Atrophy of skeletal muscle human pathology sample under microscope Atrophy of skeletal muscle human pathology sample under microscope muscular atrophy stock videos & royalty-free footage 00:14 Atrophy ...

Regulators in the U.S. and the European Union agreed to review Biogen’s applications for approval of a higher dose Spinraza ...